Pneumology Division, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Pneumology Division, Hospital Universitario Clinic de Barcelona, Barcelona, Spain.
Adv Ther. 2021 Apr;38(4):1860-1875. doi: 10.1007/s12325-021-01625-w. Epub 2021 Mar 6.
Self-perceived health-related quality of life (HRQoL) of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) and their experience with the care received are important for improving their management. We conducted a study to assess both patient-reported outcomes (PROs) and how they interrelate.
This was a cross-sectional, observational study of consecutive patients with PAH and CTEPH attending pulmonary hypertension (PH)-specialized units at 25 hospitals in Spain. PRO measurements used included CAMPHOR/EQ-5D-5L questionnaires (HRQoL) and IEXPAC (healthcare experience). Patient characteristics were collected. Relationships were analysed with Pearson's correlation coefficient and linear regression analyses.
A total of 185 patients with PAH and 93 patients with CTEPH aged 54.4 ± 14.4 and 64.8 ± 13.4 years were included: 63.6% and 72% were functional class (FC) I-II; median time from diagnosis was 3 and 2 years, respectively. Most patients with PAH received combination oral therapy. CAMPHOR scores indicated moderate-to-high impairment in the "activity" scale (PAH 21.6 ± 6.8; CTEPH 21.0 ± 6.3). EQ-5D-5L index and visual analogue scale (VAS) score (PAH 0.59 ± 0.15 and 65.55 ± 21.54; CTEPH 0.59 ± 0.13 and 66.95 ± 18.71, respectively) indicated moderate HRQoL impairment. HRQoL was mostly affected by FC. IEXPAC scores (PAH 7.08 ± 1.56 and CTEPH 7.13 ± 1.61) indicated good healthcare experience. In patients with PAH, the CAMPHOR "symptom" and "QoL" domains inversely correlated with the IEXPAC "patient self-management" factor.
In patients with long-standing PAH and CTEPH with good disease control, functional limitations greatly impact HRQoL while symptoms and generic QoL were less affected. Healthcare received was perceived as good; however, use of information and communication technologies, patient associations and promotion of self-management should improve for enhanced patient experience.
肺动脉高压(PAH)和慢性血栓栓塞性肺动脉高压(CTEPH)患者的自我感知健康相关生活质量(HRQoL)及其对所接受护理的体验对于改善治疗效果至关重要。我们进行了一项研究,以评估患者报告的结果(PROs)及其相互关系。
这是一项在西班牙 25 家医院的肺动脉高压(PH)专科单位就诊的 PAH 和 CTEPH 连续患者的横断面、观察性研究。使用的 PRO 测量包括 CAMPHOR/EQ-5D-5L 问卷(HRQoL)和 IEXPAC(医疗体验)。收集患者特征。使用 Pearson 相关系数和线性回归分析来分析关系。
共纳入 185 例 PAH 患者和 93 例 CTEPH 患者,年龄分别为 54.4±14.4 岁和 64.8±13.4 岁:63.6%和 72%为功能分级(FC)I-II 级;分别从诊断到随访中位时间为 3 年和 2 年。大多数 PAH 患者接受了联合口服治疗。CAMPHOR 评分表明“活动”量表(PAH 21.6±6.8;CTEPH 21.0±6.3)存在中度至高度损害。EQ-5D-5L 指数和视觉模拟量表(VAS)评分(PAH 0.59±0.15 和 65.55±21.54;CTEPH 0.59±0.13 和 66.95±18.71)表明存在中度 HRQoL 损害。HRQoL 主要受 FC 影响。IEXPAC 评分(PAH 7.08±1.56 和 CTEPH 7.13±1.61)表明医疗体验良好。在 PAH 患者中,CAMPHOR“症状”和“QoL”域与 IEXPAC“患者自我管理”因子呈负相关。
在疾病控制良好、病程较长的 PAH 和 CTEPH 患者中,功能障碍极大地影响 HRQoL,而症状和一般 QoL 受影响较小。所获得的医疗服务被认为是良好的;然而,为了提高患者体验,应更好地利用信息和通信技术、患者协会以及促进自我管理。